Software AG

  • WKN: A2GS40
  • ISIN: DE000A2GS401
  • Land: Germany

Nachricht vom 21.03.2007 | 17:59

Software AG: Software AG Acquires SPL Software of Israel

Software AG / Acquisition/Acquisition

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

Darmstadt – 21.3.2007 – As per April 1st, 2007 Software AG 
(Reuters: SOWGn.F, WKN: 330400) will acquire an 80.08% share in its Israeli
distributor SPL Software Ltd., based in Tel Aviv. Software AG’s supervisory
board agreed today to the transaction; the purchase price of US$ 61.6
million (€ 46.3 million) will be paid fully in cash. SPL Software currently
is wholly owned by Silverboim Holdings Ltd., Tel Aviv, which will continue
to hold the remaining shares in SPL Software.
SPL Software generates 93% of its revenue with Software AG products in the
banking and insurance industries and the public sector. SPL Software
currently has 296 employees (full time equivalents) of which 257 are IT
consultants developing industry specific solutions based on Software AG’s
product portfolio. The company is one of the market leaders in its sector
in Israel.
Due to the acquisition, Software AG expects incremental revenue of
approximately € 20 million for fiscal 2007. Therefore, the forecasted
growth in revenue for 2007 is raised from 10% to 14% (net of currency
effects). The expected increase in EPS is estimated to be € 0.10. Based on
this increase, the EPS of Software AG for fiscal 2007 is now expected to be
in the range of € 3.00 to € 3.20.

DGAP 21.03.2007 
Language:     English
Issuer:       Software AG
              Uhlandstraße 12
              64297 Darmstadt Deutschland
Phone:        +49 (0)6151 92-1938
Fax:          +49 (0)6151 92-1933
ISIN:         DE0003304002
WKN:          330400
Indices:      TecDAX
Listed:       Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in
              Berlin-Bremen, Düsseldorf, Hamburg, München, Stuttgart
End of News                                     DGAP News-Service

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

01. Dezember 2021